"Highly regarded for its standards of excellence, Clinical Research Center of Alabama, an affiliate of AllerVie Health, has been conducting clinical trials for pharmaceutical companies and Contract Research Organizations since 1998. CRCA has conducted hundreds of clinical studies in adult and pediatric patients, contributing to the advancement of new therapies for asthma, allergies, and other related conditions. Our providers are passionate about clinical research and paving the way for new and increasingly effective treatment options to help people live in freedom."

During the past decade, Clinical Research Center Of Alabama conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 25 clinical trials were completed, i.e. on average, 58.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 19 clinical trials were completed. i.e. 90.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Center Of Alabama" #1 sponsor was "Pfizer" with 11 trials, followed by "Shire" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "CSL Behring" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Center Of Alabama" #1 collaborator was "Takeda Development Center Americas, Inc." with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Sanofi" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Dyax Corp." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Center Of Alabama" are "Atopic Dermatitis" (11 trials), "Asthma" (7 trials), "Dermatitis, Atopic" (5 trials), "Eczema" (4 trials) and "Hereditary Angioedema (HAE)" (3 trials). Many other conditions were trialed in "Clinical Research Center Of Alabama" in a lesser frequency.

Most popular intervention types in "Clinical Research Center Of Alabama" are "Drug" (43 trials), "Biological" (8 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Lebrikizumab" (4 trials), "Omalizumab" (3 trials), "PF-04965842 100 mg" (3 trials) and "PF-04965842 200 mg" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Center Of Alabama" are 52 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Research Center Of Alabama". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Clinical Research Center Of Alabama, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Center Of Alabama, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 3 trials that are defined as “Not Applicable".